SULT1A1 and cancer: As the sulfation of 4-hydroxytamoxifen by SULT1A1 decreases therapeutic efficacy of tamoxifen in cancer cells [49], 6-PN and 8-PN, which increase the SULT activity in the proliferating cells, might reduce the tamoxifen treatment efficacy.